STAAR SURGICAL CO|4Sep 9, 4:03 PM ET

Blickensdoerfer Hans-Martin 4

4 · STAAR SURGICAL CO · Filed Sep 9, 2021

Form 4

Period: 2021-09-07

VP, International Marketing

Transactions

Exercise/Conversion
Common Stock
2021-09-07$27.53/sh+15,100$415,703→ 106,331 total
Sale
Common Stock
2021-09-07$157.40/sh−11,522$1,813,563→ 77,200 total
Sale
Common Stock
2021-09-07$157.40/sh−29,131$4,585,219→ 77,200 total
Exercise/Conversion
Common Stock Options
2021-09-07−14,031→ 4,109 total
Exercise: $35.98From: 2020-03-14Exp: 2029-03-13→ Common Stock (14,031 underlying)
Exercise/Conversion
Common Stock
2021-09-07$35.98/sh+14,031$504,835→ 91,231 total
Exercise/Conversion
Common Stock Options
2021-09-07−15,100→ 16,879 total
Exercise: $27.53From: 2021-03-20Exp: 2030-03-19→ Common Stock (15,100 underlying)

Footnotes (4)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.45, inclusive.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.40 to $157.46, inclusive.
[F3]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029.
[F4]The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the next 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.

Documents

1 file